Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves
naijnaira.com
منذ 4 أيام
HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX:…
The post Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves appeared first on NaijNaira.



